Loading...
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
OBJECTIVES: To assess the characteristics and risk factors for mortality in patients with severe coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in combination with corticosteroids (CS). METHODS: From March 17 to April 7, 2020, a real-world observational retrospective an...
Na minha lista:
| Udgivet i: | Int J Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537652/ https://ncbi.nlm.nih.gov/pubmed/33035673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.09.1486 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|